IP Library Granted Patent US 11,298,117
Granted Patent B2
US 11,298,117 · App. 16/738,516 · Granted Apr 12, 2022

Techniques for providing a replacement valve and transseptal communication

Inventors: Ilia Hariton (Zichron Yaackov, IL); Tal Reich (Moshav Moledet, IL); Paul Kaye (Modlin, IL)
Assignee: CARDIOVALVE LTD.
A61B17/0057A61F2/2427A61M27/002A61B2017/00247A61B2017/00575A61B2017/00592A61B2017/00597A61B2017/00606A61F2/2412A61F2/2436A61F2002/249A61F2210/0057A61M2210/125
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,298,117
App. No.
16/738,516
Granted
Apr 12, 2022
Kind
B2
Abstract

A method is provided, including (1) identifying the subject as having mitral valve regurgitation; (2) during a medical procedure, in response to identifying the subject as having mitral valve regurgitation, implanting a prosthetic valve at a mitral valve site of the heart; and (3) during the same medical procedure, implanting a therapeutic septal device at a septum of the heart. Other embodiments are also described.

Claims (42)

1. A method for use with a heart of a subject, comprising:

identifying the subject as having mitral valve regurgitation;

during a medical procedure, in response to identifying the subject as having mitral valve regurgitation, implanting a prosthetic valve at a mitral valve site of the heart; and

during the same medical procedure, implanting a shunt including a check valve at a septum of the heart such that the check valve facilitates one-way blood flow from a chamber of a left side of the heart, via the shunt, to a chamber of a right side of the heart.

2. The method according to claim 1 , wherein implanting the prosthetic valve and implanting the shunt respectively comprise implanting the prosthetic valve and implanting the shunt in an absence of an identification of the subject as having heart failure.

3. The method according to claim 1 , wherein the septum is an interatrial septum of the heart, and wherein implanting the shunt at the septum comprises implanting the shunt at the interatrial septum.

4. The method according to claim 1 , wherein the septum is an interventricular septum of the heart, and wherein implanting the shunt at the septum comprises implanting the shunt at the interventricular septum.

5. The method according to claim 1 , wherein the subject is an adult subject, and wherein the method is performed on the adult subject.

6. The method according to claim 1 , further comprising making a fenestration in the septum of the heart, and delivering the prosthetic valve transfemorally to the heart and through the fenestration to the mitral valve site, and wherein implanting the shunt comprises implanting the shunt in the fenestration.

7. The method according to claim 6 , further comprising transfemorally delivering the shunt to the septum.

8. The method according to claim 6 , wherein making the fenestration comprises making the fenestration transfemorally.

9. The method according to claim 1 , further comprising transapically making a fenestration in the septum of the heart, wherein implanting the shunt comprises implanting the shunt in the fenestration.

10. The method according to claim 1 , further comprising transapically delivering the prosthetic valve to the mitral valve site.

11. The method according to claim 1 , wherein implanting the shunt comprises implanting the shunt after implanting the prosthetic valve.

12. The method according to claim 1 , wherein implanting the shunt comprises implanting the shunt before implanting the prosthetic valve.

13. A method for use with a heart of a subject, comprising:

identifying the subject as having mitral valve regurgitation;

during a medical procedure, in response to identifying the subject as having mitral valve regurgitation, implanting a prosthetic valve at a mitral valve site of the heart; and

during the same medical procedure, implanting a shunt at a septum of the heart, the shunt being shaped to define a lumen and including a membrane that regulates blood flow through the lumen, wherein:

the membrane:

has a closed position in which the membrane inhibits blood flow through the lumen, and an open position in which the inhibiting of the blood flow by the membrane is reduced,

resides in the closed position while a blood pressure difference across the membrane is lower than a threshold blood pressure difference,

moves from the closed position into the open position in response to the blood pressure difference exceeding the threshold blood pressure difference, and

is configured such that the threshold blood pressure difference is 4-6 mmHg, and

implanting the shunt that is shaped to define the lumen and includes the membrane comprises implanting the shunt that is shaped to define the lumen and includes the membrane that:

has the closed position and the open position,

resides in the closed position while the blood pressure difference across the membrane is lower than the threshold blood pressure difference,

moves from the closed position into the open position in response to the blood pressure difference exceeding the threshold blood pressure difference, and

is configured such that the threshold blood pressure difference is 4-6 mmHg.

14. The method according to claim 13 , wherein the membrane is configured to move from the closed position into the open position in response to the blood pressure difference exceeding the threshold blood pressure difference in either direction across the membrane, and wherein implanting the shunt that includes the membrane comprises implanting the shunt that includes the membrane that is configured to move from the closed position into the open position in response to the blood pressure difference exceeding the threshold blood pressure difference in either direction across the membrane.

15. The method according to claim 13 , wherein the membrane is transected by intersecting slits, and wherein implanting the shunt comprises implanting the shunt that includes the membrane that is transected by intersecting slits.

16. The method according to claim 13 , wherein implanting the prosthetic valve and implanting the shunt respectively comprise implanting the prosthetic valve and implanting the shunt in an absence of an identification of the subject as having heart failure.

17. The method according to claim 13 , wherein the septum is an interatrial septum of the heart, and wherein implanting the shunt at the septum comprises implanting the shunt at the interatrial septum.

18. The method according to claim 13 , wherein the septum is an interventricular septum of the heart, and wherein implanting the shunt at the septum comprises implanting the shunt at the interventricular septum.

19. The method according to claim 13 , wherein the subject is an adult subject, and wherein the method is performed on the adult subject.

20. The method according to claim 13 , further comprising making a fenestration in the septum of the heart, and delivering the prosthetic valve transfemorally to the heart and through the fenestration to the mitral valve site, and wherein implanting the shunt comprises implanting the shunt in the fenestration.

21. The method according to claim 20 , further comprising transfemorally delivering the shunt to the septum.

22. The method according to claim 20 , wherein making the fenestration comprises making the fenestration transfemorally.

23. The method according to claim 13 , further comprising transapically making a fenestration in the septum of the heart, wherein implanting the shunt comprises implanting the shunt in the fenestration.

24. The method according to claim 13 , further comprising transapically delivering the prosthetic valve to the mitral valve site.

25. The method according to claim 13 , wherein implanting the shunt comprises implanting the shunt after implanting the prosthetic valve.

26. The method according to claim 13 , wherein implanting the shunt comprises implanting the shunt before implanting the prosthetic valve.

Assignments (3)
SECURITY INTEREST Recorded Jun 10, 2021
From: CARDIOVALVE LTD.
To: BEST, LAWRENCE C.; OXO CAPITAL VALVE VENTURES LLC; PEREGRINE VC INVESTMENTS IV (IL) L.P.; PEREGRINE VC INVESTMENTS IV (US INVESTORS) L.P; PEREGRINE VC INVESTMENTS IV (OTHER INVESTORS) L.P.; NGN BIOMED OPPORTUNITY II, L.P.; IF A PE FUND II, LP; IF A PE FUND II US, LP
Reel/Frame 056539/0833 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 22, 2020
From: HARITON, ILIA; KAYE, PAUL; REICH, TAL
To: MITRALTECH LTD.
Reel/Frame 053002/0146 →
CHANGE OF NAME Recorded Jun 22, 2020
From: MITRALTECH LTD.
To: CARDIOVALVE LTD.
Reel/Frame 053052/0991 →
Continuity (3)
Continuation 15433547 · Feb 15, 2017
Provisional Application 62295701 · Feb 16, 2016
Related Publication 20200315789A1 · Oct 8, 2020
Cited By (12)
US 12,396,851 US 12,408,907 US 12,414,797 US 12,527,942 US 12,575,816 US 12,611,305 US 12,653,514 US 12,678,166 US 12,678,191 US 12,690,815 US 12,691,266 US 12,697,134